Its potential in Huntington's disease emerged thanks to an AI drug screening platform operated by SOM, which is used to identify existing drugs that can be repurposed for use in new indications.

Brown-Forman Corp. Cl A-0.29% $14.78B Brown-Forman Corp. Cl B-0.74% $14.78B Carlsberg A/S Series B-0.42% kr.115.2B Carlsberg A/S Series A 0.22% kr.115.2B ...

Rights Apr 13, 2023 Apr 14, 2023 Dec 09, 2022 Rights ratio: 10 share for every 211 held at a price of Rs 140.0 Rights Dec 31, 2021 Jan 03, 2022 Jul 20, 2021 Rights ratio: 1 share for every 13 held at ...

100 Sleeping Princes and the Kingdom of Dreams: The Animation (TV) (Latin America and Spain) (Brazil and Portugal) ...